Live Breaking News & Updates on Pharma Consulting

Stay updated with breaking news from Pharma consulting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Improved Pharma announces new collaboration with Keystone Pharma Consulting

West Lafayette, IN (PRWEB) May 11, 2022 Improved Pharma is pleased to announce a collaboration with Dr. Patricia Andres from Keystone Pharma Consulting, ....

Sarah Byrn , Patricia Andres , Brett Cowans , Pamela Smith , Particle Technology , Keystone Pharma Consulting , Improved Pharma , Materials Science , Pharma Consulting , Keystone Pharma , Press Release ,

Latest Report on Electronic Data Capture System Software Market by Industry Development Trend Analysis and Forecasts 2027 – KSU

Latest Report on Electronic Data Capture System Software Market by Industry Development Trend Analysis and Forecasts 2027 – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.

United States , Electronic Data Capture System Software , Electronic Data Capture System Software Market Segment , Pharma Consulting Group , Contract Research Organizations , Customization Service Of The , Biotech Companies , Electronic Data Capture System Software Market , Phoenix Software International , Dacima Software , Key Players Profiled , Pharma Consulting , Fortress Medical , Phoenix Software , Data Capture System Software Market Segment , Customization Service , ஒன்றுபட்டது மாநிலங்களில் , மின்னணு தகவல்கள் பிடிப்பு அமைப்பு மென்பொருள் , பார்மா ஆலோசனை குழு , ஒப்பந்த ஆராய்ச்சி ஆர்கநைஸேஶந்ஸ் , தனிப்பயனாக்கம் சேவை ஆஃப் தி , பயோடெக் நிறுவனங்கள் , மின்னணு தகவல்கள் பிடிப்பு அமைப்பு மென்பொருள் சந்தை , பீனிக்ஸ் மென்பொருள் சர்வதேச , பார்மா ஆலோசனை , கோட்டை மருத்துவ ,

Exicure Announces Appointments of Elizabeth Garofalo, M.D., and Andrew Sassine to Its Board of Directors


Share:
Exicure, Inc. (NASDAQ:XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced the appointments of Elizabeth (Betsy) Garofalo, M.D. and Mr. Andrew Sassine to its Board of Directors.
We are pleased to welcome Betsy and Andrew to our Board at a critical time for Exicure, having made significant progress with the development of cavrotolimod in oncology and XCUR-FXN in Friedreich s ataxia. Betsy s distinguished career and significant clinical development experience and Andrew s financial and institutional investor experience will provide important perspective to our Board, said Timothy P. Walbert, Exicure s Chairman of the Board of Directors. We look forward to the collective experience they will bring as Exicure advances its pipeline of innovative investigational therapies and we look to deliver on the promise of Exicure s proprietary Spherical Nucleic Acid, or SNA technology. ....

Ann Arbor , United States , United Kingdom , Wharton School , Andrew Sassine , David Walt , David Giljohann , Elizabeth Betsy Garofalo , Timothyp Walbert , Fidelity Investments , Board Of Acadia Pharmaceuticals Inc , Indiana University School Of Medicine , Institute For Advanced Clinical Trials In Children , Exicure Inc , Fidelity Small Cap Stock Fund , University Of Michigan Medical School , Icad Inc , Global Development Leadership Team , Pharma Consulting , Exchange Commission , University Of Pennsylvania , Fidelity International Small Cap Opportunities Fund , Global Head Of Clinical Development For Novartis , Spherical Nucleic Acid , Senior Vice President , Global Head ,